|
The guiding scientific principle for Health Arising™ is that of Targeted Biologic Therapy™ - Each of the RxIBR developed pharmaceutical biologists and/or botanicals either activate cellular receptors in the human body or directly stimulate cellular mechanisms of the human body, thus providing a physiological/biochemical action. With Targeted Biologic Therapy™ the need to optimally stimulate specific receptors requires much less concentrated pharmaceutical quantities, therefore, the direct delivery of microgram or nanagram amounts of a biological/botanical product significantly reduces the risk of adverse and toxic side effects of the pharmaceutical agent. All of the drug products and therapies utilizing Targeted Biologic Therapy™ are manufactured under strict quality control (QC) and good manufacturing practices (GMP), and all claims, labels and promotional materials have been registered with the US-FDA and have been independently confirmed by the US patent office to be unique pharmaceutical process-products. ADD-eX™ - Specifically designed orally absorbable spray of all natural formula that has been fortified with nerve growth factors for children with attention deficit disorder or other learning disorders including hyperactive learning disorder syndrome and Downs syndromes. During prenatal development any disruption of this process may produce neuronal development may produce neuronal and mental aberrations that result in a group of syndromes called attention deficit disorders, with or without hyperactivity. The use of this health product has been found to significantly enhance learning capacity and reduce the behavioral abnormality in these children. NDC 063493-0213 and 0214 and patent #5,773,241. Cefal-eX™ - This drug product is indicated for the symptomatic relief of migraine headaches, headaches with vertigo, headaches that are worsened by noise, light and movement, blinding headaches, occipital and weary headaches, numb headaches with poor powers of concentration, dizziness with frontal headache, pain and fullness in the head, headaches with exhaustion and collapse and headaches in the forehead, occipital areas and temples. NDC 063493-0321 and 0322, patent #5,773,241. CuNeXuS™ - This is an entirely new concept in wound healing and epidermal replacement. This product contains anti-viral, nerve and epidermal regenerative factors that stimulate the normal growth of the dermas and epidermas following either surgical or other wounds: thus promoting remarkable early healing. This process not only increases the rate of wound healing but also reduces the scarring and possible keloid formation. NDC 063493-0621 (liquid), patent #7,773,241 and additional patent pending. Health Formula Two™ © - All natural formulation capsules designed to increase mental adjustment to stress, fight infectious disease, prevent fatigue and strengthen the muscles and reverse the process of aging. In addition to the ingredients in Health Formula One, Health Formula Two contains specific growth and immune stimulating factors that promote maturation of nerve and immune cell development. In addition to its anti-aging properties, this health product is extremely useful for mental and physical conditioning, vigilance and immune protection. NDC 063493-0121 and 0122 and patent #5,773,241.
MD-eX™ -
An all-natural drug product that stimulates receptors in the oral cavity
that activate a amygdaloid-hypocampal system in the brain. This
product is indicated for the treatment of emotional states of euphoria
alternating with periods of depression. It is useful in treating
depression, melancholia, neuroasthenia, nervousness, exhaustion and
collapse, psychological conditions that are associated with marked
alteration of good mood with depression. NDC 063493-0631 (liquid)
and 063493-07632, patent #7,773,241 and patent pending. N-reX™ ©
- A unique formulation that contains nerve growth factors (neurotrophins-Naja
tripudens-HPUS) that are responsible for regenerating or activating the
regeneration of neurons and are used for the treatment of Alzheimer's
Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis (Orghan
Drug) Down's Syndrome. In Alzheimer's Disease, the Wechsler Memory
Quotient (WAIS-MQ) improved 16% within 60 days. In Parkinson's
Disease the clinical signs of the disease improved 69% while, at the
same time the dosage of traditional anti-Parkinson medications were
reduced significantly. In Down's Syndrome a mean increase of 11%
to 17% was seen in the WAIS testing, over a 60 day period of time.
NDC 063493-0211 and 0212 and patent #5,773,241. O-beX™ ©-All orally absorbable spray liquid that activates weight
loss, without starvation, activation of the
thyroid or adrenal gland, stimulation of metabolic cycles or block the
absorption of fats, vitamins, and essential nutrients. This health
product is believed to depend upon stimulation of lymphocyte receptors that activate
normal lymphocyte production of zinc-activated globulins (ZAG proteins)
that, in turn, cause the lipid breakdown of fat cells (adipocytes).
Studies have shown that a mean 8.3-pound weight loss and girth may be obtained in 10 days, without dieting, in a
random group of patients. The NDC 063493-0411 and 0412, patent
#5,773,241 and *patent #09/385,989 pending. V-reX™
© (RNA-HPUS) - Is specifically formulated for an orally absorbable
spray liquid to be used for the purpose of effectively treating
influenza, respiratory infections, recurrent herpes (DNA viral infections), chronic recurring eczema and chronic fatigue
syndromes. NDC 063493-0311 and 0312 and patent #5,773,241. If you are not in a frame,
please click HERE
to be |
